Developments in the Medical Technology and Devices Market

Thursday, September 28, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

FinancialBuzz.com News Commentary

NEW YORK, September 28, 2017 /PRNewswire/ --

The medical technology

industry is a crucial part of the healthcare sector. The 'medtech' industry includes medical devices, important innovative products designed to simplify the prevention, diagnosis and treatment of diseases. A research report by market research firm Evaluate, predicts
that the global Medical Device and Technology market will grow at CAGR of 5% or more annually until 2022, reaching nearly $530 billion. "The sector is already seeing a resurgence of smaller acquisitions on which start-ups, a significant source of disruptive new technologies, depend," Ian Strickland, EvaluateMedTech product manager said of the report according to Forbes. ORHUB, Inc. (OTC: ORHB), Veeva Systems Inc (NYSE: VEEV), Streamline Health Solutions, Inc. (NASDAQ: STRM), NantHealth, Inc. (NASDAQ: NH), Medical Transcription Billing Corp. (NASDAQ: MTBC)

According to the International Trade Administration, "The global medical devices market offers tremendous opportunity for U.S. manufacturers, as well as significant challenges, for government policymakers seeking to support U.S. export competitiveness in overseas markets. The U.S. medical device industry is highly diversified and produces a variety of products to diagnose and treat patients, ranging from tongue depressors to complex programmable pacemakers. The United States medical devices industry is known for producing high quality products using advanced technology resulting from significant investment in research and development. During the last decade, the United States medical device industry experienced unprecedented advancement in innovative and developed technologies, leading to the birth of new therapies and growth in overall healthcare industry."

ORHUB, Inc. (OTC: ORHB) announced earlier today that, "The Company has added one of Southern California's leading hospital system CEO's to the Company's advisory board, to empower management with valuable guidance, resources and insight as the Company emerges from early stage development company, to full-scale cutting edge service provider.

Dr Richard Afable's insight into the the evolution that is affecting health care in America is second to none. He has been an integral thought leader that has helped to weave the fabric of the trends in hospital care for the last 20 years. He now recognizes the dramatic changes that are rapidly casting themselves on American health care. They payors of health care, the government and the employers, no longer will accept the status quo. The can no longer expend unlimited resources on health care. They have decided to create limitations on what they are willing to pay. Consequently, the reimbursement for a unit of health care in a hospital or surgical center is going to be reduced. This trend will continue and the hospital system will need to develop new tools to allow it survive financially or they will become insolvent.

"ORHub is an innovative new system that can and will provide for us the kind of information and data analytics we need in order to take better care of patients, and do it more effectively and efficiently," stated Richard Afable, MD, when he was CEO and president of Hoag Memorial Hospital in Newport Beach, in 2010. In that position, Dr Afable enabled and encouraged the founders of ORHUB, a neurosurgeon and medical device representative, to develop their system in his world class hospital, collaborating with all aspects of the hospital system. This collaborative effort expanded at Hoag Memorial Hospital under the current CEO Robert Braithwate and resulted in a world class software system."

Veeva Systems Inc (NYSE: VEEV) is a leader in cloud-based software for the global life sciences industry. Recently the company announced that is helping a growing number of medical device and diagnostics companies improve quality and efficiency to meet new compliance standards. In less than one year, Veeva has seen nearly 25% growth in medical device and diagnostics customers as organizations prepare to meet rigorous compliance requirements from global health authorities and the international standards organization (ISO).

Streamline Health Solutions, Inc. (NASDAQ: STRM) is a healthcare industry leader in capturing, aggregating, and translating enterprise data into knowledge producing actionable insights that support revenue cycle optimization for healthcare enterprises. On August 31, 2017, the company and South Shore Hospital today announced the sale of Streamline's new cloud-based automated pre-bill code auditing technology, Streamline Health® eValuator™ to Chicago-based South Shore Hospital. With eValuator, Streamline Health is leading an industry movement to improve healthcare providers' financial performance by moving mid-to-late revenue cycle interventions upstream, optimizing coding accuracy for every patient encounter prior to bill submission. By improving coding accuracy before billing, providers can reduce revenue leakage, mitigate overbill risk, and reduce denials and days in A/R. This enables providers to turn unpredictable revenue cycles into dynamic revenue streams.

NantHealth, Inc. (NASDAQ: NH) is an evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth has developed an adaptive learning system, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets billions of molecular, clinical, operational and financial data points derived from novel and traditional sources, continuously improves decision-making and further optimizes clinical pathways and decision algorithms over time. On August 7th NantHealth announced that GPS Cancer, a molecular test that helps guide cancer treatment strategies including choice of standard chemotherapy for oncologists, is now covered by Sistemas Medicos Nacionales, S.A. de C.V. (SIMNSA), a comprehensive healthcare service plan that provides quality care for patients in the cities of Tijuana, Tecate and Mexicali.

Medical Transcription Billing Corp. (NASDAQ: MTBC) is a healthcare information technology company that provides a fully integrated suite of proprietary web-based and mobile health solutions, together with related business services, to healthcare providers throughout the United States. Its integrated SaaS platform helps its customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. On August 22, 2017, the company announced that it has been selected by Infinity Diagnostic Labs, a full-service clinical and anatomical pathology laboratory as its healthcare IT and revenue cycle management vendor. MTBC first launched the laboratory division of its larger billing operations in 2014. Infinity Diagnostic Labs will serve as a cornerstone of its strategic laboratory and diagnostic billing expansion plans.

Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"

Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com 

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For this release, FinancialBuzz.com has been compensated four thousand dollars for financial news dissemination and pr services by a third party non-affiliate for orhub, inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com.

For further information:

Media Contact: [email protected] Phone:+1-877-601-1879 Url: http://www.FinancialBuzz.com

SOURCE FinancialBuzz.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook